Delivery Order SPE2DB25D3504-SPE2DB25FVVVM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,783.60 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on August 25, 2025, with completion expected by August 26, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,916.37 for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,831.88 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on July 8, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.29 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,360.56 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a $2,090.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD). This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a direct fulfillment of pharmaceutical supply needs through the federal medical procurement system. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a $2,239.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,337.70 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. The order was competitively awarded with firm fixed pricing and has an ultimate completion date of October 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the performance location for this delivery order. This award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $7,637.24 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and represents a competitively awarded transaction. The pharmaceutical supplies will be...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVVMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,181.37 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and utilized firm fixed price pricing under a non-set-aside competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the contractor to supply a comprehensive range of pharmaceuticals, medical supplies, vaccines, and specialized healthcare commodities to support military and federal healthcare systems globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill competitive procurement requirements across multiple therapeutic domains and order values, making it a critical vendor within the Defense Health Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/5/25 |